Radiation Oncologist
2015-2019, Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
2014-2015, General Surgery, Stanford University Hospital & Clinics, Stanford, CA
2013-2014, General Surgery, University of California San Francisco, San Francisco, CA
Radiation oncologist Heather McGee, M.D., Ph.D., draws inspiration from loved ones who have been diagnosed with cancer and seeing how recent advances in immunotherapy have transformed cancer care. She takes great pride in answering all of her patients’ questions and empowering them to be part of the decision-making process.
Â
Dr. McGee, M.D., Ph.D., is a physician-scientist whose lab focuses on the immune response to radiation. She graduated from University of California Berkeley with honors with a degree in molecular cell biology (biochemistry emphasis) and then earned a master’s degree in immunology at University of Cambridge. She completed her doctoral training at Yale University where she earned an M.D. and a Ph.D. in immunobiology. She worked in the laboratory of Richard Flavell, Ph.D., studying immune-fibroblast interactions during wound healing and received Yale’s Prize Teaching Fellowship for teaching immunology to undergraduates.
Dr. McGee completed her intern year at University of California San Francisco and residency training in radiation oncology at Icahn School of Medicine at Mount Sinai. She then worked as a postdoctoral fellow at the Salk Institute, where her research was funded by a Salk Women & Science Special Award and a National Institutes of Health/National Cancer Institute K99 grant.Â
At City of Hope, she is a physician-scientist who sees patients in radiation oncology and has a basic science laboratory focused on tumor immunology. Her lab is funded by the National Institutes of Health/National Cancer Institute R00 grant, the American Association for Cancer Research, Debbie's Dream Foundation Award for Gastric Cancer Research and City of Hope Chancellors' Award. Her laboratory investigations focus on the role of tissue-resident innate immune cells in response to radiation in different tumor microenvironments and she is passionate about translating scientific findings back to the clinic to create better outcomes for cancer patients.
Â